These results were in concord with the dynamic changes of CD8+ T cells we observed, in which a group of dominant clones accounted for higher clonality initially, resulting in the lower TCR diversity; whereafter, more ICIs-induced migration of T cells into the tumor led to an increase of TCR diversity in the blood.8,46. The gene discussed is CD8A; the disease is neoplasm.